What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Michael E. J. Lean focuses on Internal medicine, Endocrinology, Body mass index, Diabetes mellitus and Food science.
His study in Endocrinology is interdisciplinary in nature, drawing from both Placebo and Age of onset.
His Body mass index research includes themes of Obesity, Gerontology and Risk factor.
His study looks at the relationship between Diabetes mellitus and topics such as Surgery, which overlap with Blood pressure.
His studies in Food science integrate themes in fields like Biochemistry, Flavonols, Antioxidant, Flavonoid and Botany.
His studies deal with areas such as Anthropometry and Circumference as well as Waist.
His most cited work include:
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 (5207 citations)
- Waist circumference as a measure for indicating need for weight management (1435 citations)
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 (1425 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Obesity, Endocrinology, Body mass index and Weight loss.
Michael E. J. Lean has researched Internal medicine in several fields, including Diabetes mellitus and Gastroenterology.
His Obesity research incorporates themes from Weight gain, Disease, Gerontology and Environmental health.
His work carried out in the field of Body mass index brings together such families of science as Odds ratio, Anthropometry, Demography and Surgery.
His Weight loss research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Pediatrics and Type 2 diabetes.
His Type 2 diabetes study frequently draws connections to adjacent fields such as Clinical trial.
He most often published in these fields:
- Internal medicine (31.46%)
- Obesity (22.47%)
- Endocrinology (21.57%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (31.46%)
- Type 2 diabetes (13.48%)
- Diabetes mellitus (14.38%)
In recent papers he was focusing on the following fields of study:
Michael E. J. Lean mostly deals with Internal medicine, Type 2 diabetes, Diabetes mellitus, Weight loss and Obesity.
His biological study deals with issues like Endocrinology, which deal with fields such as Ageing.
His Type 2 diabetes study which covers Clinical trial that intersects with Pancreas.
His Diabetes mellitus study integrates concerns from other disciplines, such as Weight gain and Weight change.
His Obesity study combines topics in areas such as Body mass index, Demography, MEDLINE and Environmental health.
He focuses mostly in the field of Body mass index, narrowing it down to matters related to Gerontology and, in some cases, Cognitive decline.
Between 2015 and 2021, his most popular works were:
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (537 citations)
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (237 citations)
- A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. (205 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Obesity
His primary scientific interests are in Internal medicine, Obesity, Weight loss, Diabetes mellitus and Type 2 diabetes.
His research combines Endocrinology and Internal medicine.
Michael E. J. Lean interconnects Body mass index, Weight gain, Demography and MEDLINE in the investigation of issues within Obesity.
The various areas that Michael E. J. Lean examines in his Weight loss study include Randomized controlled trial, Pediatrics and Ghrelin.
His Diabetes mellitus research integrates issues from Surgery, Intensive care medicine, Disease, Lipid metabolism and Lipoprotein.
His work deals with themes such as Clinical trial, Pathophysiology and Calorie, which intersect with Type 2 diabetes.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
